Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 15,879 | 101,418 | 84,817 | 50,209 | 22,797 |
| Depreciation Amortization | -644 | 4,829 | 2,222 | 3,340 | 1,908 |
| Income taxes - deferred | -6,726 | -33,905 | -29,438 | -20,565 | -9,935 |
| Accounts receivable | -1,500 | -3,432 | -1,789 | -539 | 447 |
| Accounts payable and accrued liabilities | -649 | 4,757 | 515 | 680 | 2,256 |
| Other Working Capital | 6,307 | 5,539 | -4,708 | -1,064 | 9,716 |
| Other Operating Activity | 13,290 | 41,117 | 35,316 | 21,226 | 8,058 |
| Operating Cash Flow | $25,957 | $120,323 | $86,935 | $53,287 | $35,247 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | -355,066 | -258,422 | -179,571 | -92,611 |
| PPE Investments | N/A | -413 | -382 | -31 | -12 |
| Purchase Of Investment | 207,475 | 241,152 | 161,718 | 87,306 | 42,127 |
| Investing Cash Flow | $207,475 | $-114,327 | $-97,086 | $-92,296 | $-50,496 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,409 | 4,381 | 3,596 | 1,932 | 1,382 |
| Other Financing Activity | -1,228 | -21,665 | -20,819 | -5,194 | -1,888 |
| Financing Cash Flow | $181 | $-17,284 | $-17,223 | $-3,262 | $-506 |
| Beginning Cash Position | 66,329 | 77,617 | 77,617 | 77,617 | 77,617 |
| End Cash Position | 299,942 | 66,329 | 50,243 | 35,346 | 61,862 |
| Net Cash Flow | $233,613 | $-11,288 | $-27,374 | $-42,271 | $-15,755 |
| Free Cash Flow | |||||
| Operating Cash Flow | 25,957 | 120,323 | 86,935 | 53,287 | 35,247 |
| Capital Expenditure | N/A | -413 | -382 | -31 | -12 |
| Free Cash Flow | 25,957 | 119,910 | 86,553 | 53,256 | 35,235 |